Literature DB >> 18163162

Critical role of hypoxia and A2A adenosine receptors in liver tissue-protecting physiological anti-inflammatory pathway.

Alexander Choukèr1, Manfred Thiel, Dmitriy Lukashev, Jerrold M Ward, Ines Kaufmann, Sergey Apasov, Michail V Sitkovsky, Akio Ohta.   

Abstract

Whole body exposure of wild type control littermates and A2A adenosine receptor (A2AR) gene deleted mice to low oxygen containing inspired gas mixture allowed the investigation of the mechanism that controls inflammatory liver damage and protects the liver using a mouse model of T cell-mediated viral and autoimmune hepatitis. We tested the hypothesis that the inflammatory tissue damage-associated hypoxia and extracellular adenosine --> A2AR signaling plays an important role in the physiological anti-inflammatory mechanism that limits liver damage during fulminant hepatitis. After induction of T cell-mediated hepatitis, mice were kept in modular chambers either under normoxic (21% oxygen) or hypoxic (10% oxygen) conditions for 8 h. It was shown that the whole body exposure to hypoxic atmosphere caused tissue hypoxia in healthy animals as evidenced by a decrease in the arterial blood oxygen tension and increase of the plasma adenosine concentration (P < 0.05). This "hypoxic" treatment resulted in significantly reduced hepatocellular damage and attenuated levels of serum cytokines in mice with acute liver inflammation. The anti-inflammatory effects of hypoxia were not observed in the absence of A2AR in studies of A2AR gene-deficient mice or when A2AR have been pharmacologically antagonized with synthetic antagonist. The presented data demonstrate that total body hypoxia-triggered pathway provides protection in acute hepatitis and that hypoxia (upstream) and A2AR (downstream) function in the same immunosuppressive and liver tissue-protecting pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18163162      PMCID: PMC2156187          DOI: 10.2119/2007-00075.Chouker

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  43 in total

Review 1.  Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors.

Authors:  Michail Sitkovsky; Dmitriy Lukashev
Journal:  Nat Rev Immunol       Date:  2005-09       Impact factor: 53.106

Review 2.  Immune-mediated liver injury.

Authors:  Johannes Herkel; Marcus Schuchmann; Gisa Tiegs; Ansgar W Lohse
Journal:  J Hepatol       Date:  2005-04-02       Impact factor: 25.083

3.  The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?

Authors:  Michail V Sitkovsky; Akio Ohta
Journal:  Trends Immunol       Date:  2005-06       Impact factor: 16.687

Review 4.  Adenosine A2A agonists in development for the treatment of inflammation.

Authors:  Courtney M Lappas; Gail W Sullivan; Joel Linden
Journal:  Expert Opin Investig Drugs       Date:  2005-07       Impact factor: 6.206

5.  Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways.

Authors:  Elzbieta Kaczmarek; Laurie Erb; Katarzyna Koziak; Robert Jarzyna; Marcia R Wink; Olaf Guckelberger; J Krzysztof Blusztajn; Vickery Trinkaus-Randall; Gary A Weisman; Simon C Robson
Journal:  Thromb Haemost       Date:  2005-04       Impact factor: 5.249

Review 6.  Immunology of hepatitis B virus and hepatitis C virus infection.

Authors:  Barbara Rehermann; Michelina Nascimbeni
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

7.  A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells.

Authors:  Courtney M Lappas; Jayson M Rieger; Joel Linden
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

8.  Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure.

Authors:  Gerry C Macquillan; Moataz S Seyam; Peter Nightingale; James M Neuberger; Nicholas Murphy
Journal:  Liver Transpl       Date:  2005-09       Impact factor: 5.799

Review 9.  Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.

Authors:  Simon C Robson; Yan Wu; Xiaofeng Sun; Christoph Knosalla; Karen Dwyer; Keiichi Enjyoji
Journal:  Semin Thromb Hemost       Date:  2005-04       Impact factor: 4.180

10.  Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury.

Authors:  Manfred Thiel; Alexander Chouker; Akio Ohta; Edward Jackson; Charles Caldwell; Patrick Smith; Dmitry Lukashev; Iris Bittmann; Michail V Sitkovsky
Journal:  PLoS Biol       Date:  2005-05-03       Impact factor: 8.029

View more
  25 in total

1.  The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.

Authors:  Preeti Chhabra; Joel Linden; Peter Lobo; Mark Douglas Okusa; Kenneth Lewis Brayman
Journal:  Curr Diabetes Rev       Date:  2012-11

2.  Extracellular adenosine controls NKT-cell-dependent hepatitis induction.

Authors:  Meenakshi Subramanian; Radhika Kini; Manasa Madasu; Akiko Ohta; Michael Nowak; Mark Exley; Michail Sitkovsky; Akio Ohta
Journal:  Eur J Immunol       Date:  2014-02-19       Impact factor: 5.532

Review 3.  Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.

Authors:  Bruce N Cronstein; Michail Sitkovsky
Journal:  Nat Rev Rheumatol       Date:  2016-11-10       Impact factor: 20.543

Review 4.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

5.  Cutting Edge: Adenosine A2a Receptor Signals Inhibit Germinal Center T Follicular Helper Cell Differentiation during the Primary Response to Vaccination.

Authors:  Shirdi E Schmiel; Jessica A Yang; Marc K Jenkins; Daniel L Mueller
Journal:  J Immunol       Date:  2016-12-16       Impact factor: 5.422

6.  Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial barrier during acute colitis.

Authors:  C M Aherne; B Saeedi; C B Collins; J C Masterson; E N McNamee; L Perrenoud; C R Rapp; V F Curtis; A Bayless; A Fletcher; L E Glover; C M Evans; P Jedlicka; G T Furuta; E F de Zoeten; S P Colgan; H K Eltzschig
Journal:  Mucosal Immunol       Date:  2015-04-08       Impact factor: 7.313

7.  Hypoxia-induced and A2A adenosine receptor-independent T-cell suppression is short lived and easily reversible.

Authors:  Akio Ohta; Manasa Madasu; Meenakshi Subramanian; Radhika Kini; Graham Jones; Alexander Choukèr; Akiko Ohta; Michail Sitkovsky
Journal:  Int Immunol       Date:  2013-10-22       Impact factor: 4.823

8.  The adenosine A₂A receptor - myocardial protectant and coronary target in endotoxemia.

Authors:  Melissa E Reichelt; Kevin J Ashton; Xing Lin Tan; S Jamal Mustafa; Catherine Ledent; Lea M D Delbridge; Polly A Hofmann; John P Headrick; R Ray Morrison
Journal:  Int J Cardiol       Date:  2011-12-20       Impact factor: 4.164

Review 9.  The adenosinergic immunomodulatory drugs.

Authors:  Akio Ohta; Michail Sitkovsky
Journal:  Curr Opin Pharmacol       Date:  2009-06-17       Impact factor: 5.547

Review 10.  Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy.

Authors:  Stephen M Hatfield; Michail V Sitkovsky
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.